Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
inflammation
Biotech
Incyte, fresh off gaining MorphoSys drug, buys Escient for $750M
Incyte is dolloping another deal onto its 2024 partnership plate, buying San Diego-based Escient Pharmaceuticals for $750 million.
Max Bayer
Apr 23, 2024 10:43am
Sanofi axes jobs, research after 'full pipeline' shakeup
Apr 5, 2024 10:53am
AbbVie pays $48M for OSE's preclinical chronic inflammation drug
Feb 28, 2024 5:25am
AstraZeneca axes IL-33 kidney disease program after seeing data
Feb 8, 2024 5:30am
Sanofi pays $30M for first look at MeiraGTx data, shot at deals
Oct 31, 2023 1:06pm
Aiolos Bio launches with $245M to advance severe asthma med
Oct 24, 2023 7:00am